Liposomal bupivacaine for pain after brain tumor surgery
Part of Brain & nervous system, Pain clinical trials.
This study tests a long-acting numbing medicine (liposomal bupivacaine) to see if it helps control pain after brain tumor surgery. If you are having a specific type of craniotomy and do not have certain health conditions, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are scheduled for brain tumor surgery through a specific approach (frontotemporal, temporal base, or temporal occipital).
- Your overall health is classified as ASA I, II, or III (meaning you are generally healthy or have mild-to-moderate illness).
- You do not have allergies to numbing medicines like those used in dental procedures.
- You do not have a history of severe long-lasting pain or long-term use of strong painkillers.
- You are not pregnant or breastfeeding, and your body mass index (BMI) is below 35.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a long-acting numbing medicine (liposomal bupivacaine) injected near the back muscles can provide better pain relief after open upper belly surgery. It may help reduce pain and the need for other painkillers.
This trial tests if a long-lasting numbing medicine placed near the surgical site can reduce pain after a specific type of brain surgery. It may help patients recover more comfortably.
This trial tests if a long-acting numbing medicine called liposomal bupivacaine can reduce pain after video-assisted lung surgery. It aims to help patients feel better after the procedure with less need for other painkillers.
This trial tests if a long-lasting numbing medicine (bupivacaine liposomes) injected into scalp nerves can reduce pain after brain surgery. It may help you need less pain medicine and feel better after your operation.
This trial tests whether a long-acting numbing medication (liposomal bupivacaine) injected into the abdominal wall can reduce pain after laparoscopic surgery for gynecologic cancer. If effective, it may help patients recover with less discomfort and fewer painkillers.
This trial tests a long-acting painkiller injected during surgery to see if it reduces pain after keyhole (laparoscopic) procedures like gallbladder removal, hernia repair, or appendix removal. It may help you need fewer opioids and recover more comfortably.
Hear when a new Liposome Bupivacaine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.